Vaccine against COVID-19: people aged 50 and over, who are well off or have a good level of education are the most likely to be in favour of the vaccine
Our longitudinal study delivers its first results on vaccination
Our longitudinal study delivers its first results on vaccination
Interview with Professor Stringhini, RTS - Forum , 5 December 2021
A few figures to illustrate what Specchio-COVID19 is today
This longitudinal study aims to assess the impact of the pandemic on Geneva's children and adolescents.
Our COVID-19 seroprevalence study, conducted from 1 June to 7 July, has produced its first results